Mobilization of calcium from intracellular stores as one of the mechanisms underlying the antiopioid effect of cholecystokinin octapeptide

This publication has 20 references indexed in Scilit:

• Exogenous cholecystokinin (CCK) reduces neonatal rat brain opioid receptor density and CCK levels
  Developmental Brain Research, 1987
• Cholecystokinin octapeptide (CCK-8): Antagonism to electroacupuncture analgesia and a possible role in electroacupuncture tolerance
  Pain, 1986
• Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous antiopioid substrates?
  Neuropeptides, 1985
• ICI 174864: A highly selective antagonist for the opioid Δ-receptor
  European Journal of Pharmacology, 1984
• Diltiazem and verapamil preferentially block inactivated cardiac calcium channels
  Journal of Molecular and Cellular Cardiology, 1983
• Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia
  Science, 1983
• Calcium channels: direct identification with radioligand binding studies
  Trends in Pharmacological Sciences, 1982
• Caerulein and cholecystokinin suppress β-endorphin-induced analgesia in the rat
  European Journal of Pharmacology, 1982
• Distribution of cholecystokinin (CCK) in the hypothalamus and limbic system of the rat
  Neuropeptides, 1981
• The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay
  Brain Research, 1981